DJIA 17,813.39 1.20 0.01%
NASDAQ 5,116.14 13.34 0.26%
S&P 500 2,088.87 -0.27 -0.01%
market minute promo

MannKind Corp (NASDAQ: MNKD)

2.19 -0.01 (-0.45%)

REAL-TIME: Last trade at

Extended Hours: $2.19 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

MNKD $2.19 -0.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.19
Previous Close $2.20
Daily Range $2.14 - $2.20
52-Week Range $1.76 - $7.88
Market Cap $896.8M
P/E Ratio -6.88
Dividend (Yield) $0.00 (0.0%)
Volume 2,809,360
Average Daily Volume 8,519,374
Current FY EPS -$0.28




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

3 Earnings Reports That Surprised Us This Quarter

Visa, MannKind, and WOOF top the list of surprises for these Motley Fool contributors.

NASDAQ Companies With Largest Short Interest

MannKind: Weekly Data Updates- 11-13-15 Data

MannKind (MNKD) Stock Gains After CEO Resigns

MannKind Elder Abuse Is Replacing Inept CEO With Founder

Benzinga's Top #PreMarket Losers

MannKind's Desperation Move Comes Up Short -- Now What?

MannKind's stock offering in Israel misses the mark, leaving the company with few viable options left to raise capital.

Why MannKind's Listing in Israel Might Not Matter

A listing in Israel may provide some cash, but it's unlikely to be enough unless sales of Afrezza ramp.

MannKind (MNKD) Shows Strength: Stock Moves Up 18.9%

MannKind Share Sale Strategy

See More MNKD News...

MNKD's Top Competitors

MNKD $2.19 (-0.45%)
Current stock: MNKD
AMGN $163.95 (0.72%)
Current stock: AMGN
GILD $107.78 (1.14%)
Current stock: GILD
BIIB $292.30 (1.09%)
Current stock: BIIB